Physician profile
Jose E Valerio
NPI 1619148293
$106,187.81
in general payments reported to CMS, 2019-2025
34 companies · $9,016 in 2025
The $9,016 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,585 · 2020: $1,234 · 2021: $9,816 · 2022: $29K · 2023: $24K · 2024: $27K · 2025: $9,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Food and Beverage: $6,480 · Travel and Lodging: $4,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,425.00 |
| Food and Beverage | $6,480.20 |
| Travel and Lodging | $4,805.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $80,555.16 | 2020-2025 | Everest Spinal System, Xia 3, Stryker Nav3 |
| Si-Bone, INC. | $10,890.01 | 2019-2025 | |
| Vb Spine LLC | $4,878.11 | 2025 | Yukon Oct Spinal System, Everest Spinal System, Siros |
| Brainlab, INC. | $2,874.39 | 2019-2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Boston Scientific Corporation | $1,193.93 | 2019-2023 | |
| Medtronic, INC. | $1,182.94 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Mazor X System |
| Carl Zeiss Meditec USA, INC. | $660.92 | 2024-2025 | Intrabeam 600, Iort |
| Camber Spine Technologies LLC | $656.10 | 2021 | |
| Biocomposites INC | $409.49 | 2019-2023 | Stimulan |
| Implanet America, INC. | $371.45 | 2025 | |
| Orthofix Medical, INC. | $283.80 | 2020-2021 | |
| Abbott Laboratories | $272.64 | 2024-2025 | Infinity, Eterna |
| Integrity Implants INC. | $225.74 | 2022 | |
| Saluda Medical Americas, INC. | $187.14 | 2025 | Evoke |
| Clearpoint Neuro, INC. | $179.20 | 2024-2025 | Clearpoint |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $166.00 | 2019-2023 | Teligen |
| Livanova USA, INC. | $160.70 | 2019-2020 | |
| Novocure INC. | $144.72 | 2019-2024 | Optune |
| Medical Device Business Services, INC. | $130.24 | 2024 | Teligen |
| Sk Life Science, INC. | $117.13 | 2021-2025 | |
| Longeviti Neuro Solutions INC | $101.93 | 2025 | Clearfit |
| Surgalign Spine Technologies, INC. | $81.73 | 2019 | |
| Varian Medical Systems, INC. | $73.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $73.51 | 2019-2020 | |
| Spine Wave, INC. | $66.97 | 2024 | Spinal Implant |
| Providence Medical Technology, INC. | $53.35 | 2022 | |
| Alevio, LLC | $42.12 | 2019 | |
| Nalu Medical, INC. | $33.00 | 2021 | |
| Integra Lifesciences Corporation | $28.68 | 2020 | |
| Ossdsign USA Incorporated | $23.31 | 2024 | |
| Medtronic USA, INC. | $19.30 | 2019 | |
| Biedermann Motech, INC. | $18.90 | 2019 | |
| Ethicon US, LLC | $16.55 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Valerio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.